A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors
about
Adenomatous polyposis coli (APC) is required for normal development of skin and thymusThe tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phaseIn vivo bio-imaging using chlorotoxin-based conjugatesWnt/beta-catenin signaling and small molecule inhibitorsInactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignanciesActivator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cellsManipulation of DNA Repair Proficiency in Mouse Models of Colorectal CancerMouse models for the discovery of colorectal cancer driver genesMouse models of intestinal cancerColorectal cancer models for novel drug discoveryUnderstanding phenotypic variation in rodent models with germline Apc mutationsAnimal models of colorectal cancerMulti-level interactions between the nuclear receptor TRα1 and the WNT effectors β-catenin/Tcf4 in the intestinal epitheliumCancer stemness in Apc- vs. Apc/KRAS-driven intestinal tumorigenesisSonic Hedgehog promotes tumor cell survival by inhibiting CDON pro-apoptotic activityPreclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancerA common role for various human truncated adenomatous polyposis coli isoforms in the control of beta-catenin activity and cell proliferationExpression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathwayThe genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse modelAPC-dependent suppression of colon carcinogenesis by PPARgammaSomatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activityLoss of adenomatous polyposis coli gene function disrupts thymic developmentAneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and humanApc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and developmentNotch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestineDevelopmental abnormalities in multiple proliferative tissues of Apc(Min/+) miceEssential role of beta-catenin in postnatal bone acquisitionA knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers.Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursorsMechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.Mouse models of colorectal cancer.p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse.Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturationMurine models of colorectal cancer.Insights into cancer from transgenic mouse models.Bacterial oncogenesis in the colonMouse models for colorectal cancer.Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.Genetic and Chemical Models of Colorectal Cancer in Mice.
P2860
Q21145258-8B3671E4-4E1B-4BF7-818C-817471E3B7CDQ24310213-BBB9D4D5-3A3D-42F3-81B3-C8F358E842E1Q24595399-92C92758-F66C-4BBE-A344-38345D6B21D0Q24597197-8A8FC364-A8A4-4633-9D6C-54730C134D3FQ24647958-AF4BD6E7-1DEE-46B0-A9B3-F612B0CE45C0Q24648448-4421E08B-3760-4DFB-9812-3F7C99068092Q26740310-F014C06C-AD71-49FE-A18C-C0929C28E694Q26774627-35D6CC95-F5B2-45D8-8EF6-4FFE8D29DFF0Q26785563-88FC274C-FD86-4FB2-811F-F930E778B109Q26795724-57553323-F2ED-4AA4-9817-94732AF42705Q26824920-5CF238F9-A578-4783-8B59-3717196E908DQ27009170-161DEB4D-10AD-4788-99E4-5E3310331348Q27305398-643C9DBC-D9B2-4A50-A7D1-5BB05E0BF86AQ27307633-6E79BE8A-992D-4494-A1B1-9270A42C0F1AQ27317023-27FDE81A-B75E-4F33-88F7-6E2A5940D016Q28252635-8987B2E9-CE26-4000-ADC3-9005101A6341Q28482101-344E240A-8370-4BC7-9702-D65581D4C8E9Q28505373-9301D35C-D8C9-4CA0-8675-09BC926C5BDAQ28506414-44089F79-E692-4C30-90FA-6D378E60F172Q28506424-7F05CF56-21A7-470A-B129-DB1BEDB8E6C0Q28507875-7B1A89C9-1712-4FA7-B908-1DEC4B325A0CQ28508640-CAC5D922-58E0-4EDE-A566-DCCD71694D34Q28510491-D67A245B-F8EC-4BF8-8EFB-EBB254AA8802Q28511030-AA31879F-6EFC-4F61-BCE6-1D8A86ACF5B1Q28586202-4AA4BE59-842C-4924-AD20-9018C47B914EQ28586284-ED1D63DD-4FDA-47EC-A5AF-AC2D99955060Q28594492-E4F8E117-5F84-4A37-AE7D-220CF3140E1FQ30424003-42599EFD-D106-4360-B914-7ABE836822FBQ33208221-B3AA6A09-CE3F-4D85-8F8B-725873A07876Q33428306-C89B83DF-1C9D-45DD-A3F3-06F3111F0E10Q33536327-70F8AD34-BA28-4532-811D-838F7C7D20CFQ33579734-13A48B39-8C32-400B-882A-CC820E1F7468Q33610527-8487D10F-AE0C-43E6-BEAC-2C82A5165396Q33611148-45EF5E21-D084-45FE-B1C5-7A0869D8D81CQ33640905-CAC45AD8-F75F-450E-A1D6-F8BA6C7A0238Q33643327-FA848A6C-7414-4748-B2C8-6FD40D9C4658Q33737879-07E72B6C-92AF-4BC5-B4C1-8C08A2BB4DD2Q33739279-DFA59489-5C28-4E0B-9C9E-16A18C5EE140Q33754989-956A82D7-9CAB-4F1A-BCEC-A3D2E1EDC8A3Q33771627-F12E5B58-9181-4A48-962E-9F4AC3670F68
P2860
A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
A targeted chain-termination m ...... in multiple intestinal tumors
@ast
A targeted chain-termination m ...... in multiple intestinal tumors
@en
A targeted chain-termination m ...... in multiple intestinal tumors
@nl
type
label
A targeted chain-termination m ...... in multiple intestinal tumors
@ast
A targeted chain-termination m ...... in multiple intestinal tumors
@en
A targeted chain-termination m ...... in multiple intestinal tumors
@nl
prefLabel
A targeted chain-termination m ...... in multiple intestinal tumors
@ast
A targeted chain-termination m ...... in multiple intestinal tumors
@en
A targeted chain-termination m ...... in multiple intestinal tumors
@nl
P2093
P2860
P3181
P356
P1476
A targeted chain-termination m ...... in multiple intestinal tumors
@en
P2093
C van Leeuwen
W Edelmann
P2860
P304
P3181
P356
10.1073/PNAS.91.19.8969
P407
P577
1994-09-13T00:00:00Z